INO - Inovio Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INO is currently covered by 6 analysts with an average price target of $14.4. This is a potential upside of $12.67 (732.37%) from yesterday's end of day stock price of $1.73.

Inovio Pharmaceuticals's activity chart (see below) currently has 96 price targets and 114 ratings on display. The stock rating distribution of INO is 57.89% HOLD and 42.11% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.34% with an average time for these price targets to be met of 495.25 days.

Highest price target for INO is $18, Lowest price target is $3, average price target is $10.13.

Most recent stock forecast was given by GREGORY RENZA from RBC on 19-Mar-2025. First documented stock forecast 18-Jun-2014.

Currently out of the existing stock ratings of INO, 11 are a HOLD (57.89%), 8 are a BUY (42.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5

$3.27 (189.02%)

$6

11 days ago
(19-Mar-2025)

13/19 (68.42%)

$3.04 (155.10%)

417

Hold

$3

$1.27 (73.41%)

$3

11 days ago
(19-Mar-2025)

3/7 (42.86%)

$1.04 (53.06%)

1200

Buy

$18

$16.27 (940.46%)

16 days ago
(14-Mar-2025)

1/2 (50%)

$15.97 (786.70%)

67

Buy

$15

$13.27 (767.05%)

$33

4 months 12 days ago
(18-Nov-2024)

2/5 (40%)

$10.92 (267.65%)

367

Buy

$15

$13.27 (767.05%)

$33

4 months 12 days ago
(18-Nov-2024)

0/2 (0%)

$10.92 (267.65%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INO (Inovio Pharmaceuticals) average time for price targets to be met?

On average it took 495.25 days on average for the stock forecasts to be realized with a an average price target met ratio 73.34

Which analyst has the current highest performing score on INO (Inovio Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on INO (Inovio Pharmaceuticals)?

Charles Duncan works at CANTOR FITZGERALD and has 12 price targets and 8 ratings on INO

Which analyst is the currently most bullish on INO (Inovio Pharmaceuticals)?

Thomas Shrader with highest potential upside - $130.27

Which analyst is the currently most reserved on INO (Inovio Pharmaceuticals)?

Jason Kolbert with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?